Navigation Links
Onyx Pharmaceuticals Files Complaint Against Bayer Corporation
Date:5/17/2009

Asserts Rights to Phase 2 Anti-Cancer Compound Discovered During Joint Research

EMERYVILLE, Calif., May 17 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it has filed a complaint in the United States District Court for the Northern District of California asserting its rights to a Phase 2 anti-cancer compound discovered during joint research between Onyx and Bayer. In its complaint, Onyx seeks a declaration that fluoro-sorafenib is a jointly-owned collaboration compound under the Bayer/Onyx collaboration agreement, together with other remedies. The defendants in the complaint are Bayer Corporation and Bayer A.G. Onyx affirmed that it continues to collaborate with Bayer in the development and commercialization of Nexavar.

Onyx was recently advised that the compound, fluoro-sorafenib, is a variant of Nexavar(R) (sorafenib) tablets and has the same chemical structure as Nexavar, except that a single fluorine atom has been substituted for a hydrogen atom. The new molecule had been identified in 1998 during the research collaboration period by the companies' joint research teams. Discussions with Bayer regarding Onyx's rights to fluoro-sorafenib under the companies' 1994 collaboration agreement were not productive.

Greg Giotta, Ph.D., J.D., vice president and chief legal counsel of Onyx, said, "Onyx and Bayer have had a long-standing and successful collaboration for more than 15 years. Against that background, we are disappointed that we could not resolve this matter and believe this complaint is necessary to protect our rights and the rights of our shareholders under the collaboration agreement."

About Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer.
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Poniard Pharmaceuticals Files Shelf Registration
2. OncoGenex Pharmaceuticals Announces Release of Two ASCO Abstracts: Impact of OGX-011 on Survival in Randomized Phase 2 Trial and Phase 1 Safety Data for OGX-427
3. Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting
4. Ausio Pharmaceuticals to Present at Bio(R) 2009
5. VIA Pharmaceuticals Announces Complete Enrollment in FDG-PET Phase 2 Study of VIA-2291 in Cardiovascular Patients
6. Poniard Pharmaceuticals to Present at the Leerink Swann Oncology Roundtable Conference
7. Amylin Pharmaceuticals to Present at Deutsche Bank Health Care Conference
8. Poniard Pharmaceuticals to Present at the 2009 BIO International Convention
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on First Quarter 2009 Financial Results on Thursday, May 14, 2009 at 8:30am EDT
10. Arena Pharmaceuticals Announces First Quarter 2009 Financial Results
11. Idenix Pharmaceuticals to Present at The Deutsche Bank 2009 Health Care Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...HOPKINTON, Mass., Dec. 3 ...eading provider of tools and services for drug dis...d Living Image 4.0 software for IVIS® in vivo... more than 800 Caliper IVIS systems currently inst...features advanced spectral unmixing tools to enhan...
(Date:12/2/2009)..., NEW YORK, Dec. 2 Reportlinker...s available in its catalogue: ,, Carbondioxide...http://www.reportlinker.com/p0164368/Carbondioxide..., Incubators are the most critical equipment us...d other applications for providing a controlled en...
(Date:12/2/2009)..., CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Onco...) (TSX:ONC; NASDAQ: ONCY ) announced today that in...ering, the underwriters have exercised in full the...al 637,500 units. Each unit is comprised of one co...ant, and was sold at a price of US$3.00 per unit. ...
(Date:12/2/2009)..., SINGAPORE, Dec. 2 S*BIO Pte Lt...oral JAK2 inhibitor, SB1518, at The American Socie...n in New Orleans. ,, Data will be presented on ...ion trial of SB1518 detailing its safety, tolerabi...rofile in dose levels ranging from 100 to 600 mg. ...
Breaking Biology Technology:Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5
...May Minimize Viral Transmission, Including Norovir...zer may significantly impact public health by mini...ding norovirus, from food handlers and care provid...a, Ontario, Canada, and North Carolina State Unive... 2008 issue of the journal Applied and Environmen...
...iversity researcher has created a compound that pr...nd could lead to a treatment for the disease. , "...aths and thousands of illnesses, and there is curr...rofessor that led the molecular design team. "Alth...ncern that SARS could return or be used as a biolo...
...Sensors & Controls™ (Gems), a global lea...iniature solenoid valves, and fluidic systems has ...nsors. The UCL-520 Series is suitable for non-cont...t, wastewater management, chemical storage as well... Plainville, CT (Vocus) Dec...
Other Biology Technology:Tips from the journals of the American Society for Microbiology 2Tips from the journals of the American Society for Microbiology 3Tips from the journals of the American Society for Microbiology 4Purdue researcher invents molecule that stops SARS 2Purdue researcher invents molecule that stops SARS 3GEMS Introduces Ultrasonic Continuous Liquid Level Sensor for Challenging Fluid Measurement 2
(Date:12/4/2009)..., A major discovery is challenging accepted thinki...sociated with diseases such as Alzheimer,s and Par... therapeutics. , It was believed that amyloid fi...ometimes known as fibres - are inert, but that the...h can damage cells and cause disease. , But in ...
(Date:12/3/2009)..., Our ability to learn new information and adapt t...retain lifelong memories, appears to lie in the mi...rding to a new study by NYU Langone Medicine Cente...week in the journal Nature . , The scientists,...physiology and neuroscience at NYU School of Medic...
(Date:12/3/2009)...Contents of this message: , , Preliminary Pre...p to California Academy of Sciences museum, Atte..., NCSWA holiday dinner registration deadline 10..., News Media Registration Form pre-registration d... , For important information regarding visas fo...
Breaking Biology News(10 mins):New therapy targets for amyloid disease 2Lifelong memories linked to stable nerve connections 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6Foreign Physician Growth in the U S and the Impact on Medical Credentialing 55645 1Foreign Physician Growth in the U S and the Impact on Medical Credentialing 55645 2Foreign Physician Growth in the U S and the Impact on Medical Credentialing 55645 3Diet to Go Asks 3A Isn 26apos 3Bt it TIME You Listened to the Facts About Weight Loss 3F 55642 1Diet to Go Asks 3A Isn 26apos 3Bt it TIME You Listened to the Facts About Weight Loss 3F 55642 2Diet to Go Asks 3A Isn 26apos 3Bt it TIME You Listened to the Facts About Weight Loss 3F 55642 3Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B 28R 29 for Over the Counter Use 55640 1Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B 28R 29 for Over the Counter Use 55640 2
...prehensive national study of how carbon dioxide em...isheries, marine mammals, coral reefs, and other n... the National Science Foundation. , "Carbon diox...ng of fossil fuels is not only contributing to atm...ski, director of scientific programs and chief sci...
... Ariz. Oct. 21, 2008 TGen has spun off its third...ical information source for oncologists. , The fo...a variety of data sources, including genetic-based...sed Translational Genomics Research Institute. , ...ncologists with the knowledge they need to design ...
... New South Wales (UNSW) research has highlighted a...t before and during pregnancy. The work in animals... likely to have babies with more body fat, who are...isorders later in life. , Previous research shows...nt are overweight. , The research, published in t...
Other Biology News:NOAA and NSF commission national study of ocean acidification 2TGen spin-off MedTrust Online enables cancer doctors to quickly obtain best-available information 2Overweight mums have chubby bubs 2
... clone 8G8/5 GenBank Accession Number : NM_002542...ma fusion protein corresponding to residues 166-22...an AP-2γ Formulation: 0.1M Tris-glycine, pH ...ition of glycerol to 30% Quality Assurance: routin...
Rabbit Anti-Human Secretory Carrier Membrane Protein 2 (SCAMP2) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
Mouse Anti-Mucin 3 (MUC3) Ab-2 Monoclonal Antibody, Unconjugated, Clone 1143/B7 from Lab Vision
...the caudal-related homeobox family, is an intestin...h proliferation and differentiation in intestinal ...iggering cells towards the phenotype of differenti...nce of the phenotype. Clone CDX2-88 reacts with a ...
Biology Products: